Explore more publications!
Sci-Tech Portal St. Lucia
Got News to Share?

Sci-Tech Portal St. Lucia: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech Portal St. Lucia.

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on December 30, 2025

データボルトAI、ワラントの配当案を発表
Dec. 30, 2025

データボルトAI、ワラントの配当案を発表

Indeterminate GlobeNewswire
Datavault AI Inc., 워런트 배당 계획 발표
Dec. 30, 2025

Datavault AI Inc., 워런트 배당 계획 발표

Indeterminate GlobeNewswire
Datavault AI Inc. ประกาศเสนอการจ่ายปันผลเป็นวอร์แรนท์
Dec. 30, 2025

Datavault AI Inc. ประกาศเสนอการจ่ายปันผลเป็นวอร์แรนท์

Indeterminate GlobeNewswire
Datavault AI Inc. 宣布拟派发认股权证股息
Dec. 30, 2025

Datavault AI Inc. 宣布拟派发认股权证股息

Indeterminate GlobeNewswire
Datavault AI Inc. 宣佈擬派發認股權證股息
Dec. 30, 2025

Datavault AI Inc. 宣佈擬派發認股權證股息

Indeterminate GlobeNewswire
Carahsoft Named Distributor of the Year for 2025 by Cyturus
Dec. 30, 2025

Carahsoft Named Distributor of the Year for 2025 by Cyturus

Indeterminate GlobeNewswire
Cycurion Closes Transformative 2025 with $80 Million Contracted Backlog and Book Value of $2.00 Per Share – Accelerating into 2026
Dec. 30, 2025

Cycurion Closes Transformative 2025 with $80 Million Contracted Backlog and Book Value of $2.00 Per Share – Accelerating into 2026

Indeterminate GlobeNewswire
Easy Environmental Solutions Announces Availability Of EasyFEN Liquid Microbial Production System
Dec. 30, 2025

Easy Environmental Solutions Announces Availability Of EasyFEN Liquid Microbial Production System

Indeterminate GlobeNewswire
Palisade Bio Announces Granting of Japanese Patent Covering Composition of Matter for Lead Product Candidate, PALI-2108
Dec. 30, 2025

Palisade Bio Announces Granting of Japanese Patent Covering Composition of Matter for Lead Product Candidate, PALI-2108

Indeterminate GlobeNewswire
374Water Awarded Waste Destruction Services Funding from the State of Minnesota for PFAS Destruction in Biosolids
Dec. 30, 2025

374Water Awarded Waste Destruction Services Funding from the State of Minnesota for PFAS Destruction in Biosolids

Indeterminate GlobeNewswire
Vocodia Enters Mass Tort Sector With AI-Driven Intake, Marketing, and Lead Generation Platform
Dec. 30, 2025

Vocodia Enters Mass Tort Sector With AI-Driven Intake, Marketing, and Lead Generation Platform

Indeterminate GlobeNewswire
Snail Inc. Closes the Year with High Engagement Across Core IPs, Signaling Strong Momentum Into 2026
Dec. 30, 2025

Snail Inc. Closes the Year with High Engagement Across Core IPs, Signaling Strong Momentum Into 2026

Indeterminate GlobeNewswire
IMUNON Announces Pricing of $7.0 Million Registered Direct Offering Priced At-The-Market Under NASDAQ Rules
Dec. 30, 2025

IMUNON Announces Pricing of $7.0 Million Registered Direct Offering Priced At-The-Market Under NASDAQ Rules

Indeterminate GlobeNewswire
VivoPower to Add $10 Million Proforma EBITDA from Proposed Acquisition of 40MW+ Energized Norway Data Center Ready for Sovereign AI Pivot
Dec. 30, 2025

VivoPower to Add $10 Million Proforma EBITDA from Proposed Acquisition of 40MW+ Energized Norway Data Center Ready for Sovereign AI Pivot

Indeterminate GlobeNewswire
SciSparc: Neurothera Labs Granted Patent by Israeli Patent Office for its Proprietary Opioid-Based Patent Family to Enhance Pain Relief and Reduce Side Effects
Dec. 30, 2025

SciSparc: Neurothera Labs Granted Patent by Israeli Patent Office for its Proprietary Opioid-Based Patent Family to Enhance Pain Relief and Reduce Side Effects

Indeterminate GlobeNewswire
Oxylabs AI Predictions for 2026: Greater Impact with Fewer Breakthroughs
Dec. 30, 2025

Oxylabs AI Predictions for 2026: Greater Impact with Fewer Breakthroughs

Indeterminate GlobeNewswire
Silo Pharma Executes Letter of Intent with Allucent to Support Phase 1 Clinical Development of SPC-15
Dec. 30, 2025

Silo Pharma Executes Letter of Intent with Allucent to Support Phase 1 Clinical Development of SPC-15

Indeterminate GlobeNewswire
Collegium Announces the Closing of $980 Million Syndicated Credit Facility
Dec. 30, 2025

Collegium Announces the Closing of $980 Million Syndicated Credit Facility

Indeterminate GlobeNewswire
Seyond Announces $2.6M Collaboration with Aventi Sweden to Enhance Market Presence
Dec. 30, 2025

Seyond Announces $2.6M Collaboration with Aventi Sweden to Enhance Market Presence

Indeterminate GlobeNewswire
The New England Journal of Medicine Publishes Phase 1/2 Study of Denali Therapeutics’ Tividenofusp Alfa (DNL310) for Hunter Syndrome (MPS II)
Dec. 30, 2025

The New England Journal of Medicine Publishes Phase 1/2 Study of Denali Therapeutics’ Tividenofusp Alfa (DNL310) for Hunter Syndrome (MPS II)

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions